Mumbai: Alkem Laboratories Limited has approved the initiation of a forensic audit following an incident involving the alleged misappropriation of funds by a former employee.

The company's Audit Committee approved the audit on October 21, 2026, to examine the circumstances surrounding the incident, identify the root cause and recommend appropriate corrective measures.

The forensic audit will be conducted by Grant Thornton Bharat LLP, which will undertake a preliminary review of electronically stored information (ESI) and market intelligence relating to procurement activities carried out by the former employee. The firm will independently investigate suspected irregularities in certain transactions affecting Alkem Laboratories and examine the facts and circumstances associated with the matter.

The audit is intended to establish the circumstances surrounding the suspected financial irregularities and identify the underlying cause. It will also help determine appropriate corrective measures based on the findings of the investigation. The company has not provided further details about the alleged misappropriation or the specific transactions under scrutiny in its announcement.

Alkem Laboratories is an Indian pharmaceutical company established in 1973 and engaged in the development, manufacture and marketing of pharmaceutical products. The company operates in the domestic and international pharmaceutical markets, with a portfolio that includes branded generics, generic medicines and speciality pharmaceutical products. Its operations cover multiple therapeutic areas, including anti-infectives, cardiology, neurology, dermatology, gastroenterology and other medical segments.

The company's pharmaceutical business includes the development and manufacturing of medicines for different healthcare needs. Its activities encompass pharmaceutical product development, manufacturing and commercial distribution through established sales and marketing networks.

The forensic audit will examine suspected irregularities associated with procurement activities undertaken by the former employee and certain transactions affecting the company. Grant Thornton Bharat LLP will assist in reviewing electronically stored information and market intelligence to establish the facts and circumstances of the matter and recommend appropriate corrective measures.

Also Read: Alkem Labs Sets Up UAE Arm with AED 3.67 Million Investment to Boost Global Expansion

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .